PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q1 2022 PAVmed Inc Earnings Call Transcript

May 12, 2022 / 08:30PM GMT
Release Date Price: €13.09 (-14.57%)
Operator

Good day, and welcome to the PAVmed Inc. First Quarter Business Update Call. Today's conference is being recorded. And now at this time, I'd like to turn the conference over to Adrian Miller. Please go ahead, sir.

Adrian K. Miller
PAVmed Inc. - VP of IR

Thanks, operator. Good afternoon, everyone. This is Adrian Miller, Vice President of Investor Relations at PAVmed. Thank you for participating in today's business update call. Joining me today on the call is Dr. Lishan Aklog, Chairman and Chief Executive Officer of PAVmed; along with Dennis McGrath, President and Chief Financial Officer of PAVmed.

The press release announcing our business update and financial results will be posted shortly on PAVmed's website. Please take a moment to read the disclaimer about the forward-looking statements in the press release. The business update press release and this conference call both include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot